Home/Filings/4/0001144204-18-027745
4//SEC Filing

MARSHBANKS TRACY 4

Accession 0001144204-18-027745

CIK 0001023024other

Filed

May 10, 8:00 PM ET

Accepted

May 11, 6:30 PM ET

Size

9.8 KB

Accession

0001144204-18-027745

Insider Transaction Report

Form 4
Period: 2018-05-09
Transactions
  • Sale

    Common Stock

    2018-05-09$62.05/sh20,517$1,273,080430,084 total(indirect: See Footnote)
  • Sale

    Common Stock

    2018-05-10$62.14/sh17,685$1,098,946412,399 total(indirect: See Footnote)
  • Sale

    Common Stock

    2018-05-10$62.03/sh24,229$1,502,925388,170 total(indirect: See Footnote)
Footnotes (4)
  • [F1]This transaction was executed in multiple trades at prices ranging from $62.00 to $62.335. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This transaction was executed in multiple trades at prices ranging from $62.00 to $62.5425. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $62.00 to $62.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]Held by FA Private Equity Fund IV, L.P., FA Private Equity Fund IV GmbH & Co. Beteiligungs KG, The Productivity Fund IV Liquidating Trust, and The Productivity Fund IV Advisors Fund Liquidating Trust, which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1
  • filerCIK 0001579618

Filing Metadata

Form type
4
Filed
May 10, 8:00 PM ET
Accepted
May 11, 6:30 PM ET
Size
9.8 KB